✦ LIBER ✦

Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1

✍ Scribed by Brian D. Green; Nigel Irwin; Nicola A. Duffy; Victor A. Gault; Finbarr P.M. O'Harte; Peter R. Flatt

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-lasting antidiabetic effect of a di

✍ Rémy Burcelin; Wanda Dolci; Bernard Thorens 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 644 KB

Dipeptidyl peptidase IV inhibitors in di

✍ Martin C. Michel; Eric Fliers; Cornelis J. F. Van Noorden 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 88 KB

A kinetic study of glucagon-like peptide

✍ Anne-Marie Lambeir; Paul Proost; Simon Scharpé; Ingrid De Meester 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Regulation of the biological activity of

✍ Drucker, Daniel J.; Shi, Qing; Crivici, Anna; Sumner-Smith, Martin; Tavares, Wen 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 657 KB

Rebuttal to Deacon and Holst: “Metformin

✍ Hans-Ulrich Demuth; Simon A Hinke; Raymond A Pederson; Christopher H.S McIntosh 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Dipeptidyl peptidase IV resistant analog

✍ C. F. Deacon; L. B. Knudsen; K. Madsen; F. C. Wiberg; O. Jacobsen; J. J. Holst 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 211 KB